Evidence map›Paper›PMID 32890064›Full record

ReviewJournal of clinical neurophysiology : official publication of the American Electroencephalographic Society2020

Markers in Status Epilepticus Prognosis.

Ayham Alkhachroum, Caroline A Der-Nigoghossian, Clio Rubinos, Jan Claassen

Abstract readReview
In one paragraph

Review in Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pathophysiology of Status Epilepticus Revisited.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Epidemiology and Outcomes of Status Epilepticus.International journal of general medicine · 2021
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ayham AlkhachroumDepartment of Neurology, Columbia University, New York, New York, U.S.A.; and.
Caroline A Der-NigoghossianDepartment of Neurology, Columbia University, New York, New York, U.S.A.; and.
Clio RubinosDepartment of Neurology, Columbia University, New York, New York, U.S.A.; and.
Jan ClaassenDepartment of Neurology, Columbia University, New York, New York, U.S.A.; and.

Funding

Miami Clinical and Translational Science InstituteUL1TR002736 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CARRASQUILLO, OLVEEN, KOBETZ, ERIN N · 2018 to 2022
$23.2M
RECONFIG - REcovery of CONsciousness Following Intracerebral hemorrhaGeR01NS106014 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLAASSEN, JAN · 2019 to 2023
$3.6M
BAsIC - Brain-computer-interface practical Application in the Intensive Care unit: a pilot studyR03NS112760 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLAASSEN, JAN · 2019 to 2020
$162k
NCATS NIH HHS UL1 TR002736NINDS NIH HHS R01 NS106014NINDS NIH HHS R03 NS112760
6 · The paper itself

Abstract

Status epilepticus (SE) is a neurologic emergency with high morbidity and mortality. The assessment of a patient's prognosis is crucial in making treatment decisions. In this review, we discuss various markers that have been used to prognosticate SE in terms of recurrence, mortality, and functional outcome. These markers include demographic, clinical, electrophysiological, biochemical, and structural data. The heterogeneity of SE etiology and semiology renders development of prognostic markers challenging. Currently, prognostication in SE is limited to a few clinical scores. Future research should integrate clinical, genetic and epigenetic, metabolic, inflammatory, and structural biomarkers into prognostication models to approach "personalized medicine" in prognostication of outcomes after SE.

Indexed as

BiomarkersClinical Decision-MakingElectroencephalographyForecastingHumansInflammation MediatorsPrecision MedicinePrognosisRecurrenceStatus EpilepticusBiomarkersInflammation Mediators

Identifiers

PMID32890064
PMCPMC7864547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.